← Back to Clinical Trials
Recruiting NCT06177743

IRIS-Coroflex NEO Cohort

Trial Parameters

Condition Coronary Artery Stenosis
Sponsor Seung-Jung Park
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 19 Years
Max Age N/A
Start Date 2025-01-09
Completion 2026-12-31
Interventions
Coroflex ISAR NEO stent

Brief Summary

The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.

Eligibility Criteria

Inclusion Criteria: 1. Patients ≥ 19 years old 2. Patients receiving Coroflex ISAR NEO stents. 3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: 1. Patients with a mixture of other DESs 2. Terminal illness with life expectancy \<1 year. 3. Patients with cardiogenic shock

Related Trials